Osmotica's Research and Development Pipeline maximizes the synergies of our expertise, capacity, and intellectual property. Our pipeline is divided into three distinct categories:

  1. An internal proprietary development program focused on new and improved treatments for CNS disorders. Our R&D pipeline targets unmet medical and commercial needs.
  2. A leverage of our core capabilities to develop partnered products for commercialization outside our therapeutic focus. These products often include challenging development hurdles that require our type of specialized expertise.
  3. An innovation that enhances the scope of our current drug delivery solutions. Our technology pipeline includes continued advances and improvements to the Osmodex® technologies as well as other controlled-release delivery technologies.